Attention Investors: Don’t Miss Out on the Opportunity to Lead the Applied Therapeutics Class Action Lawsuit
Robbins Geller Rudman & Dowd LLP
SAN DIEGO, Dec. 18, 2024 (GLOBE NEWSWIRE) —
Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Applied Therapeutics, Inc. (NASDAQ: APLT) securities between January 3, 2024 and December 2, 2024, inclusive (the “Class Period”), have until February 18, 2025 to seek appointment as lead plaintiff of the Applied Therapeutics class action lawsuit.
Captioned Alexandru v. Applied Therapeutics, Inc., No. 24-cv-09715 (S.D.N.Y.), the Applied Therapeutics class action lawsuit charges Applied Therapeutics and certain of Applied Therapeutics’ top executives with violations of the Securities Exchange Act of 1934.
As an investor in Applied Therapeutics, you have the opportunity to take a stand against alleged violations of the law by joining this class action lawsuit. This is a chance for you to seek justice and potentially recover any damages incurred as a result of these violations. By becoming the lead plaintiff, you can lead the charge in holding Applied Therapeutics and its executives accountable for their actions.
Robbins Geller Rudman & Dowd LLP is a leading law firm with a track record of success in securities litigation. They are dedicated to representing investors who have been harmed by corporate misconduct and are committed to seeking justice on behalf of their clients.
Don’t miss out on this opportunity to make a difference and potentially recover losses from your investment in Applied Therapeutics. Take action now and seek appointment as lead plaintiff in the Applied Therapeutics class action lawsuit.
How This Will Affect You:
As an investor in Applied Therapeutics, being a part of this class action lawsuit could potentially help you recover any losses incurred during the Class Period. By seeking appointment as the lead plaintiff, you have the opportunity to take a stand against alleged violations committed by the company and its executives. This could lead to a favorable outcome for you and other investors affected by the misconduct.
How This Will Affect the World:
Class action lawsuits against corporations hold them accountable for their actions and serve as a deterrent against future misconduct. By pursuing legal action against Applied Therapeutics, investors are sending a message that corporate fraud and violations will not be tolerated. This could lead to greater transparency and accountability in the corporate world, ultimately benefiting investors and the public at large.
Conclusion:
Don’t miss out on the opportunity to lead the Applied Therapeutics class action lawsuit with Robbins Geller Rudman & Dowd LLP. By seeking appointment as lead plaintiff, you can make a difference and potentially recover any losses incurred during the Class Period. Take action now and stand up for your rights as an investor.
